Business
American Cancer Society and Guardant Health Partner to Expand Cancer Screening Access and Advance Health Equity
Together, American Cancer Society and Guardant Health aim to remove barriers and increase cancer screening rates in communities that have historically
About this update from Guardant Health, Inc.
[{"type":"text","content":"\nTogether, American Cancer Society and Guardant Health aim to remove barriers and increase cancer screening rates in communities that have historically limited access to preventive cancer care.\n\n\n SAN FRANCISCO--(BUSINESS WIRE)--\nThe American Cancer Society (ACS) today announced a new partnership with Guardant Health (Nasdaq: GH), a leading precision oncology company focused on improving access to cancer screening and advancing health equity.\n\nThis press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250804054617/en/\nThis collaboration supports ACS’s nationwide cancer screening efforts, including the I Love You, Get Screened public awareness campaign; community-based health system partnerships; and state coalition work aimed at removing barriers to lifesaving screenings. ACS and Guardant Health aim to increase awareness, promote early detection, and improve outcomes for individuals in communities that have historically experienced limited access to preventive care.\n\n\n“Regular cancer screening saves lives by finding certain cancers early, when they are often easier to treat or even prevent altogether,” said Maria Olson, Executive Vice President, American Cancer Society. “With support from Guardant Health, we can reach more people across the Bay Area with the information, tools, and services they need to take action for their health.”\n\n\nDespite being a hub of healthcare innovation, California continues to fall behind the national average in key cancer screening rates. Data from the American Cancer Society shows that only 64% of California women aged 45 and older are up to date on screening mammograms, compared to 69% nationally. Colorectal cancer screening rates are also lower, with 60% of eligible Californians screened compared to 62% nationwide. These gaps represent a critical opportunity to expand access and close the screening disparity.\n\n\nIn 2025, an estimated 2,041,910 people in the U.S. will be diagnosed with cancer, and more than 600,000 lives are expected to be lost due to cancer. However, due to reductions in smoking and advances in early detection and treatment, cancer mortality has dropped 34% from 1991 to 2022, averting approximately 4.5 million deaths during that time. This work aims to accelerate that momentum, with a special focus on communities th...